COVID-19 and rheumatology: first steps towards a different future?

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic

(2020) Francesca Romana Spinelli et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

(2020) Sara Monti et al.   ANNALS OF THE RHEUMATIC DISEASES

Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?

(2020) Maurizio Guastalegname et al.   CLINICAL INFECTIOUS DISEASES

Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)

(2020) J. Wu et al.   JOURNAL OF INTERNAL MEDICINE

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE